NO20075825L - Fremgangsmater og preparater til modulering og pavisning av WISP-aktivitet - Google Patents
Fremgangsmater og preparater til modulering og pavisning av WISP-aktivitetInfo
- Publication number
- NO20075825L NO20075825L NO20075825A NO20075825A NO20075825L NO 20075825 L NO20075825 L NO 20075825L NO 20075825 A NO20075825 A NO 20075825A NO 20075825 A NO20075825 A NO 20075825A NO 20075825 L NO20075825 L NO 20075825L
- Authority
- NO
- Norway
- Prior art keywords
- wisp
- modulating
- methods
- demonstrating
- preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0331—Animal model for proliferative diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/105,876 US7455834B2 (en) | 2002-06-29 | 2005-04-14 | Methods and compositions for modulating and detecting WISP activity |
| PCT/US2006/014008 WO2006113402A1 (en) | 2005-04-14 | 2006-04-13 | Methods and compositions for modulating and detecting wisp activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20075825L true NO20075825L (no) | 2008-01-11 |
Family
ID=36809580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20075825A NO20075825L (no) | 2005-04-14 | 2007-11-13 | Fremgangsmater og preparater til modulering og pavisning av WISP-aktivitet |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7455834B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1869086B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4979684B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101320261B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101198623B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006236649B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0612184A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2604933C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2388993T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL186095A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007012798A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20075825L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ561709A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2412201C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006113402A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200708738B (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7455834B2 (en) * | 2002-06-29 | 2008-11-25 | Genentech, Inc. | Methods and compositions for modulating and detecting WISP activity |
| BR112014019741A2 (pt) | 2012-02-11 | 2020-12-22 | Genentech, Inc | Usos de um antagonista da via wnt, uso de uma terapia anticâncer, método de identificação de um indivíduo com câncer, métodos para prever, método de inibição da proliferação de uma célula de câncer, uso de um antagonista da translocação de r-spondina e antagonista da translocação de r-spondina isolado |
| KR20150134346A (ko) * | 2013-03-27 | 2015-12-01 | 지이 헬스케어 에이에스 | 진단 조성물을 제조하기 위한 방법 및 시약 |
| CN106456732A (zh) * | 2014-04-15 | 2017-02-22 | 索伦托治疗有限公司 | 结合wisp1的抗体疗法 |
| KR102011366B1 (ko) * | 2016-11-17 | 2019-10-14 | 연세대학교 산학협력단 | 암 전이 억제제의 스크리닝 방법 |
| EP4365299A3 (en) * | 2018-05-17 | 2024-08-07 | Olives Biotherapeutics Inc. | Pharmaceutical composition comprising ccn5 as active ingredient for preventing or treating retinal disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| ATE406441T1 (de) | 1997-10-29 | 2008-09-15 | Genentech Inc | Verwendung des wnt-1 induzierten sekretierten polypeptids wisp-1 |
| PT1623990E (pt) | 1999-03-08 | 2008-03-18 | Genentech Inc | Composições e métodos para o tratamento de tumores |
| JP4636497B2 (ja) | 2002-06-29 | 2011-02-23 | ジェネンテック, インコーポレイテッド | Wisp活性を調節し検出するための方法及び組成物 |
| US7455834B2 (en) | 2002-06-29 | 2008-11-25 | Genentech, Inc. | Methods and compositions for modulating and detecting WISP activity |
| JP2007505131A (ja) | 2003-09-11 | 2007-03-08 | ジェネンテック・インコーポレーテッド | Wispアンタゴニストの使用方法 |
-
2005
- 2005-04-14 US US11/105,876 patent/US7455834B2/en not_active Expired - Lifetime
-
2006
- 2006-04-13 AU AU2006236649A patent/AU2006236649B2/en not_active Ceased
- 2006-04-13 MX MX2007012798A patent/MX2007012798A/es active IP Right Grant
- 2006-04-13 BR BRPI0612184A patent/BRPI0612184A8/pt active Search and Examination
- 2006-04-13 CA CA2604933A patent/CA2604933C/en not_active Expired - Fee Related
- 2006-04-13 NZ NZ561709A patent/NZ561709A/en not_active IP Right Cessation
- 2006-04-13 WO PCT/US2006/014008 patent/WO2006113402A1/en not_active Ceased
- 2006-04-13 JP JP2008506722A patent/JP4979684B2/ja not_active Expired - Lifetime
- 2006-04-13 KR KR1020077023542A patent/KR101320261B1/ko not_active Expired - Fee Related
- 2006-04-13 RU RU2007142005/10A patent/RU2412201C2/ru not_active IP Right Cessation
- 2006-04-13 ZA ZA200708738A patent/ZA200708738B/xx unknown
- 2006-04-13 EP EP06750127A patent/EP1869086B1/en not_active Expired - Lifetime
- 2006-04-13 CN CN2006800215473A patent/CN101198623B/zh not_active Expired - Lifetime
- 2006-04-13 ES ES06750127T patent/ES2388993T3/es not_active Expired - Lifetime
-
2007
- 2007-09-20 IL IL186095A patent/IL186095A/en not_active IP Right Cessation
- 2007-11-13 NO NO20075825A patent/NO20075825L/no not_active Application Discontinuation
-
2008
- 2008-10-20 US US12/254,649 patent/US7732567B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN101198623A (zh) | 2008-06-11 |
| ES2388993T3 (es) | 2012-10-22 |
| IL186095A (en) | 2012-10-31 |
| CA2604933C (en) | 2014-07-08 |
| CN101198623B (zh) | 2013-06-12 |
| AU2006236649A2 (en) | 2008-07-24 |
| IL186095A0 (en) | 2008-01-20 |
| ZA200708738B (en) | 2009-01-28 |
| BRPI0612184A8 (pt) | 2017-12-26 |
| US7732567B2 (en) | 2010-06-08 |
| NZ561709A (en) | 2009-12-24 |
| AU2006236649A1 (en) | 2006-10-26 |
| CA2604933A1 (en) | 2006-10-26 |
| AU2006236649B2 (en) | 2012-03-29 |
| JP2008537958A (ja) | 2008-10-02 |
| MX2007012798A (es) | 2007-11-20 |
| KR101320261B1 (ko) | 2013-10-22 |
| HK1112470A1 (en) | 2008-09-05 |
| EP1869086A1 (en) | 2007-12-26 |
| US20060147453A1 (en) | 2006-07-06 |
| RU2007142005A (ru) | 2009-05-20 |
| KR20080003344A (ko) | 2008-01-07 |
| RU2412201C2 (ru) | 2011-02-20 |
| JP4979684B2 (ja) | 2012-07-18 |
| EP1869086B1 (en) | 2012-07-18 |
| WO2006113402A1 (en) | 2006-10-26 |
| BRPI0612184A2 (pt) | 2011-12-20 |
| US20090148448A1 (en) | 2009-06-11 |
| US7455834B2 (en) | 2008-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022027096A2 (pt) | Composições e métodos relacionados a agentes terapêuticos ativáveis | |
| AR119683A1 (es) | Anticuerpos y receptores de antígeno quimérico específicos para receptor huérfano 1 similar a receptor de tirosina quinasa (ror1) | |
| DK2016102T3 (da) | Kimære T-cellereceptorer og tilhørende materialer og fremgangsmåder til anvendelse | |
| EP2352523A4 (en) | IMPROVED ANTI-CD19 ANTIBODIES | |
| FI4074331T3 (fi) | Koostumuksia ja menetelmiä entsyymien internalisoimiseksi | |
| WO2014074532A3 (en) | Compositions and methods for modulating cell signaling | |
| WO2004013180A3 (en) | Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof | |
| WO2020023888A3 (en) | Compositions and methods for tcr reprogramming using target specific fusion proteins | |
| PE20091931A1 (es) | Proteinas de dominio de armazon basadas en fibronectina multivalentes | |
| IN2012DN02981A (cg-RX-API-DMAC7.html) | ||
| NO20064134L (no) | Modifiserte bouganinproteiner, cytotoksiner og fremgangsmater og anvendelser derav | |
| EA200701211A1 (ru) | Полипептиды, которые связываются с br3, и их применение | |
| PE20091405A1 (es) | Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf | |
| EP2155874A4 (en) | FUSION PROTEINS OF COLLAGEN BINDING DOMAIN AND PARATHORMON | |
| ATE463512T1 (de) | Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern | |
| AR065373A1 (es) | Proteinas de fusion de inmunoglobulina y metodos de elaboracion | |
| WO2012054321A3 (en) | Assays, methods and kits for predicting renal disease and personalized treatment strategies | |
| WO2015014794A8 (en) | Use of alpha-crystallin b (cryab) in the assessment of heart failure | |
| ATE370970T1 (de) | Antagonistische humane anti-hfas-ligand- antikörper und fragmente davon | |
| WO2005074985A3 (en) | Methods of modulating cd200 and cd200r | |
| CO2021009297A2 (es) | Variantes de alfa-galactosidasa humana | |
| DE60322882D1 (de) | T zell-subpopulation zur regelung der darmimmunität | |
| MXPA05011085A (es) | Composiciones y metodos relacionados a stop-1. | |
| WO2004003158A3 (en) | Methods and compositions for modulating and detecting wisp activity | |
| ATE342979T1 (de) | 15571, ein neues gpcr-ähnliches molekül der secretin-ähnlichen familie und dessen verwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |